The Manufacturers Life Insurance Company Sells 1,038 Shares of Amedisys, Inc. (NASDAQ:AMED)

The Manufacturers Life Insurance Company cut its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 4.6% during the 3rd quarter, Holdings Channel reports. The firm owned 21,599 shares of the health services provider’s stock after selling 1,038 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Amedisys were worth $2,085,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of AMED. SG Americas Securities LLC lifted its position in shares of Amedisys by 413.4% in the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock valued at $18,985,000 after buying an additional 158,398 shares during the last quarter. Highbridge Capital Management LLC raised its stake in Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after acquiring an additional 83,200 shares during the period. Murchinson Ltd. lifted its holdings in Amedisys by 69.2% during the 2nd quarter. Murchinson Ltd. now owns 123,979 shares of the health services provider’s stock valued at $11,381,000 after purchasing an additional 50,716 shares during the last quarter. Calamos Advisors LLC boosted its position in Amedisys by 11.6% during the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after purchasing an additional 41,220 shares during the period. Finally, Canada Pension Plan Investment Board increased its holdings in shares of Amedisys by 61.0% in the second quarter. Canada Pension Plan Investment Board now owns 79,200 shares of the health services provider’s stock valued at $7,271,000 after purchasing an additional 30,000 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Trading Up 1.5 %

Shares of AMED stock opened at $86.03 on Monday. Amedisys, Inc. has a 12-month low of $84.06 and a 12-month high of $98.95. The company has a market capitalization of $2.82 billion, a PE ratio of 34.14, a price-to-earnings-growth ratio of 1.79 and a beta of 0.73. The firm has a 50 day moving average price of $93.71 and a two-hundred day moving average price of $95.30. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the previous year, the company earned $0.98 EPS. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, analysts predict that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.